GET DAILY SIGNALSRKLB vs SPCX: Rocket Lab's Momentum Meets SpaceX's Scale and Diversification
Key Takeaways
- RKLB operates as a vertically integrated launch and space-systems provider advancing its medium-lift Neutron rocket, while SPCX functions as a broad space, connectivity, and AI platform valued near $2 trillion.
- The companies operate at very different scales: Rocket Lab posts roughly $234 million in quarterly revenue, compared with SpaceX's approximately $7.8 billion in its latest quarter.
- Starlink generates profits for SpaceX, yet the firm continues heavy AI investments and reports net losses overall; Rocket Lab also remains unprofitable while funding Neutron development.
- Rocket Lab has shown renewed strength through contract wins and the Iridium acquisition, whereas SpaceX has advanced on Starship and AI developments even with upcoming lockup-related share supply.
- Both stocks command premium valuations based on long-term execution, so the choice centers on growth certainty versus scale and diversification.
Why This Comparison Matters
Rocket Lab and SpaceX stand at the heart of the ongoing commercialization of space. Although both run launch operations and build spacecraft, they hold distinct places in the value chain and trade differently in public markets. This comparison helps investors and traders evaluate a focused, higher-growth challenger against a dominant, diversified platform. Looking at business models, recent results, and positioning clarifies the trade-offs and how an AI-driven lens might weigh their relative appeal right now.
Rocket Lab's Setup and Latest Results
RKLB (Rocket Lab USA, Inc.) integrates launch services with space systems. Its Electron rocket leads in small-launch missions, while the HASTE vehicle supports suborbital defense work. The company is also developing Neutron, a reusable medium-lift rocket slated for late 2026 that many see as the key growth driver. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Recent trading has turned positive for Rocket Lab. After dropping sharply from a 52-week high near $151 into the low-$60s over the summer, shares have climbed more than 10% lately as several factors aligned. These include the largest commercial Electron deal yet—a 20-launch contract with Japan's Synspective—and approval for the roughly $8 billion Iridium acquisition, expected to close by mid-2027. Cathie Wood's ARK Invest has continued adding to its position. In the most recent quarter, revenue rose 62% year over year to $234.1 million, with Space Systems revenue up 94% and backlog at $2.36 billion. The company stays unprofitable and carries a premium price-to-sales multiple versus peers, so its valuation hinges on Neutron's successful launch.
SpaceX's Reach and Performance
SPCX (Space Exploration Technologies Corp.) began trading publicly in June 2026 in one of the largest IPOs on record. The business spans three areas: Space with reusable vehicles like Falcon 9 and Starship, Connectivity through the Starlink broadband network, and an emerging AI cloud and infrastructure segment. From what I see, the breadth here sets it apart from more specialized peers.
SpaceX's latest quarter showed revenue of $7.8 billion, up 92% year over year, led by Starlink connectivity revenue of $4.3 billion (up 66%) and AI revenue near $2.6 billion (up almost 250%). Starlink serves as the profit center with about 12 million subscribers, but the overall company still posts net losses amid heavy capital spending, including roughly $15.8 billion on AI capacity. Shares have rallied recently on Starship progress and analyst support, reaching highs not seen since June before easing back. The stock sits below its post-IPO peak near $225, and insider lockup expirations through December represent an ongoing supply factor.
Side-by-Side View
The most obvious difference is scale. SpaceX is a mega-cap entity with launch, satellite connectivity, and AI compute streams and a market value in the low trillions. Rocket Lab is a multi-billion-dollar player whose outlook depends on moving from small launch into medium-lift and space systems. Growth paths also vary: Rocket Lab centers on Neutron delivery, defense backlog, and the Iridium integration, while SpaceX focuses on Starlink growth, Starship cost cuts, and turning AI infrastructure into revenue.
Both stocks have gained ground lately, though for separate reasons. Rocket Lab has rebounded from oversold levels on contract news and the M&A move, while SpaceX has moved higher on technical milestones and upgrades. Risks differ too: Rocket Lab faces concentrated execution catalysts, whereas SpaceX deals with massive capital needs and lockup supply. Sector overlap exists in launch and defense, but SpaceX's AI and connectivity businesses provide wider diversification. Sentiment remains positive for both, yet valuations assume successful delivery on multiple fronts.
AI-Assisted Perspective on the Pair
Considering factors such as trend consistency, stability, catalysts, and positioning, an AI-driven view would likely see SPCX as the more diversified and resilient option near term, thanks to its profitable Starlink unit, multiple growth areas, and a technical trend that has held above key averages. At the same time, RKLB could offer stronger risk-reward for momentum strategies targeting a rebound from a sharp decline. Because both outlooks rest on execution that remains unproven, any AI assessment would stay probabilistic and adjust with new trend and volatility signals.
Using AI Trading Bots in Practice
When reviewing names like these, I sometimes turn to Tickeron's AI Trading Bots to test how automated strategies might handle similar setups across different timeframes and risk levels. The platform offers a wide range of bots with distinct approaches, and reviewing their historical performance on comparable tickers can add a useful layer to manual analysis without replacing it.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Experienced trader focused on market analysis, identifying trading opportunities, and developing custom trading signals based on market trends, price action, and data-driven insights. Join my Trader Club to follow my latest analysis, trading ideas, and active signals: https://tickeron.com/app/trader-club/103/view?tab=active§ion=trades&via=john
SPCX sees its Stochastic Oscillator ascending out of oversold territory
On November 09, 2026, the Stochastic Oscillator for SPCX moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 37 instances where the indicator left the oversold zone. In 9 of the 37 cases the stock moved higher in the following days. This puts the odds of a move higher at over 24%.
Technical Analysis (Indicators)
Bullish Trend Analysis
Following a +6.57% 3-day Advance, the price is estimated to grow further. Considering data from situations where SPCX advanced for three days, in 27 of 180 cases, the price rose further within the following month. The odds of a continued upward trend are 15%.
SPCX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on SPCX as a result. In 38 of 123 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 31%.
The Moving Average Convergence Divergence Histogram (MACD) for SPCX turned negative on October 13, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 57 similar instances when the indicator turned negative. In 21 of the 57 cases the stock turned lower in the days that followed. This puts the odds of success at 37%.
SPCX moved below its 50-day moving average on October 22, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for SPCX crossed bearishly below the 50-day moving average on October 27, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 4 of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 24%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where SPCX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 28%.
The Aroon Indicator for SPCX entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 9 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: SPCX's P/B Ratio (13.912) is slightly higher than the industry average of (5.050). SPCX has a moderately low P/E Ratio (-122.064) as compared to the industry average of (17.247). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.110). Dividend Yield (0.000) settles around the average of (0.055) among similar stocks. P/S Ratio (69.444) is also within normal values, averaging (18.367).
The Tickeron Price Growth Rating for this company is 34 (best 1 - 100 worst), indicating steady price growth. SPCX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 35 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 78, placing this stock slightly better than average.
The Tickeron PE Growth Rating for this company is 61 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 93 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
Industry AerospaceDefense
Advertisement